News

CytoSorbents Announces $6.25 Mln Stock Financing; Agrees With Avenue Capital On A Debt Amendment

NASDAQ

(RTTNews) - CytoSorbents Corp. (CTSO), a medical device company specializing in blood purification technologies, Friday announced a $6.25 million stock financing and an agreement with Avenue Capital Group to reduce debt and extend its loan maturity.

Read the full Veytics brief

We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.